Measurement of the human immune response to meningococcal lipooligosaccharide antigens by using serum to inhibit monoclonal antibody binding to purified lipooligosaccharide.
about
Development, characterization, and biological properties of meningococcal immunotype L3,7,(8),9-specific monoclonal antibodiesInfectious diseases associated with complement deficiencies.Nonopsonic phagocytosis of group C Neisseria meningitidis by human neutrophilsThe (alpha2-->8)-linked polysialic acid capsule and lipooligosaccharide structure both contribute to the ability of serogroup B Neisseria meningitidis to resist the bactericidal activity of normal human serum.Anti-Gal binds to pili of Neisseria meningitidis: the immunoglobulin A isotype blocks complement-mediated killing.Sialylation of Neisseria meningitidis lipooligosaccharide inhibits serum bactericidal activity by masking lacto-N-neotetraoseHuman lipooligosaccharide IGG that prevents endemic meningococcal disease recognizes an internal lacto-N-neotetraose structure.Affinity-purified human immunoglobulin G that binds a lacto-N-neotetraose-dependent lipooligosaccharide structure is bactericidal for serogroup B Neisseria meningitidis.Meningococcal group A lipooligosaccharides (LOS): preliminary structural studies and characterization of serotype-associated and conserved LOS epitopes.Production and characterization of monoclonal antibodies to type 8 lipooligosaccharide of Neisseria meningitidis.Specificity of subcapsular antibody responses in Ethiopian patients following disease caused by serogroup A meningococci.Antibodies to meningococcal class 1 outer membrane proteins in South African complement-deficient and complement-sufficient subjects.
P2860
Q28378767-4DFF5F83-6B4F-45A1-B193-3ABADC413511Q30450183-25546EF4-30B3-4E0D-9678-4C2C4A3570F7Q33751449-23C6CAE7-C5B7-4A02-82A5-87F11A0B632EQ33769638-6FEA08FD-011C-4B25-B9EE-477333EF2BC9Q35458135-D43401F3-A9F7-4032-8C7D-AAA0A4631A7BQ35557535-7994A718-1A26-4701-A03A-39039C21DF46Q35626087-034845F0-BB0A-4F82-BC8C-CCB146EB7012Q35689237-85D52A4B-D1FD-432E-B746-1D72439A8DD5Q35778475-1696F722-B3B9-45DF-8500-9D90D523CB1CQ37125206-355B21D5-A373-4DF5-91D1-E664718C32C1Q38606992-6C778B42-0A4B-4D1D-AEC4-051D5C6A39FCQ40152035-A2F82815-0271-46E3-AEA0-D07A8623E77E
P2860
Measurement of the human immune response to meningococcal lipooligosaccharide antigens by using serum to inhibit monoclonal antibody binding to purified lipooligosaccharide.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh
1990年學術文章
@zh-hant
name
Measurement of the human immun ...... purified lipooligosaccharide.
@en
type
label
Measurement of the human immun ...... purified lipooligosaccharide.
@en
prefLabel
Measurement of the human immun ...... purified lipooligosaccharide.
@en
P2093
P2860
P1476
Measurement of the human immun ...... purified lipooligosaccharide.
@en
P2093
Estabrook MM
Griffiss JM
Mandrell RE
P2860
P304
P407
P577
1990-07-01T00:00:00Z